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Abstract
Randomization is a hallmark of clinical trials. If a trial entails very few subjects and has many prognostic factors (or many
factor levels) to be balanced, minimization is a more efficient method to achieve balance than a simple randomization. We
propose a novel minimization method, the ‘two-way minimization’. The method separately calculates the ‘imbalance in the
total numbers of subjects’ and the ‘imbalance in the distributions of prognostic factors’. And then to allocate a subject, it
chooses—by probability—to minimize either one of these two aspects of imbalances. As such, it is a method that is both
treatment-adaptive and covariate-adaptive. We perform Monte-Carlo simulations to examine its statistical properties. The
two-way minimization (with proper regression adjustment of the force-balanced prognostic factors) has the correct type I
error rates. It also produces point estimates that are unbiased and variance estimates that are accurate. When there are
important prognostic factors to be balanced in the study, the method achieves the highest power and the smallest variance
among randomization methods that are resistant to selection bias. The allocation can be done in real time and the
subsequent data analysis is straightforward. The two-way minimization is recommended to balance prognostic factors in
small trials.
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Introduction
Random allocation of subjects is a hallmark of clinical trials.
The simplest allocation method is the ‘simple randomization’
(complete randomization with equal allocation) where the
recruited subjects are assigned to treatment group or control
group based entirely on probabilities (say, using random numbers,
or computer-generated random variates) [1]. In a large trial, a
straightforward simple randomization often suffices to achieve
satisfactory balance between the treatment and the control
groups—with respect to the total numbers of subjects and to the
distributions of prognostic factors [2].
If a trial entails very few subjects and has many prognostic factors
(or many factor levels) to be balanced, one may need to resort to a
more sophisticated method of ‘minimization’ [3,4]. The method
achieves balance not by probability but by design. Thus it is a
more efficient method statistically as compared with the simple
randomization [5,6,7]. Minimization has one notable drawback,
however—its allocation of subjects becomes predictable to some
extent. As such, selection bias may arise and the credibility of the
trial can be questioned.
In this paper, we propose a novel minimization method, the ‘two-
way minimization’. The method separately calculates the ‘imbalance in
the total numbers of subjects’ and the ‘imbalance in the distributions of
prognostic factors’. And then to allocate a subject, it chooses—by
probability—to minimize either one of these two aspects of imbalances.
We perform Monte-Carlo simulations to compare the performances of
the two-way minimization with five existing randomization methods.
Methods
Imbalance Measures
Consider an arbitrary point during the trial. Let nT and nC
denote the total numbers of subjects allocated to the treatment
group and the control group, respectively. The imbalance in the
total numbers of subjects is simply d~ nT{nC jj .
Suppose that a total of m prognostic factors (indexed by j) are to
be balanced, with a total of Lj levels (indexed by k) for the j th
prognostic factor. Let nT
jk denote the number of subjects allocated
to the treatment group, whose j th prognostic factor is at the
k th level. Let nC
jk denote the corresponding number of subjects
allocated to the control group. We then calculate the proportions
(distributions): qT
jk~
nT
jk
P Lj
l~1
nT
jl
~
nT
jk
nT
and qC
jk~
nC
jk
P Lj
l~1
nC
jl
~
nC
jk
nC
. The
imbalance in the distributions of the j th prognostic factor is
defined as dj~
P Lj
k~1
qT
jk{qC
jk
     
     : The overall imbalance in the
distributions is a weighted sum of dj’s, that is, D~
P m
j~1
dj
Lj
:
Two-Way Minimization
At the beginning, we let the trial adopt a simple randomization
scheme for allocating subjects. After nTw0 and nCw0, we then
shift to two-way minimization.
The proposed two-way minimization is an adaptive randomi-
zation procedure [7]. In fact, it is adaptive in two ways: (A1)
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28604Figure 1. Performances of the two-way minimization using different ª values, under a smaller sample size of n~20 (left panels,
A,D: the average effect of the prognostic factors is smaller,  b b~0:5; right panels, E,H: the average effect of the prognostic factors
is larger,  b b~1:5; solid circle: with three binary prognostic factors; hollow circle: with six binary prognostic factors; cross: with three
polytomous prognostic factors.
doi:10.1371/journal.pone.0028604.g001
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PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28604Figure 2. Performances of the two-way minimization using different ª values, under a larger sample size of n~40 (left panels, A,D:
the average effect of the prognostic factors is smaller,  b b~0:5; right panels, E,H: the average effect of the prognostic factors is
larger,  b b~1:5; solid circle: with three binary prognostic factors; hollow circle: with six binary prognostic factors; cross: with three
polytomous prognostic factors.
doi:10.1371/journal.pone.0028604.g002
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(treatment-adaptive), and (A2) minimizing the imbalance in the
distributions of prognostic factors (covariate-adaptive). That is,
(A1) minimizing d:
If dw0, the new subject is to be allocated to the group with
fewer subjects already in that group, otherwise, to the treatment
and control groups with equal probability.
(A2) minimizing D:
Let DT be the overall imbalance in the distributions of
prognostic factors if the new subject is allocated to the treatment
group, and DC, the overall imbalance if allocated to the control
group. We then actually allocate the new subject to the treatment
group if DTvDC, to the control group if DTwDC, and to the
treatment and control groups with equal probability if DT~DC.
We let chance dictate which rule (A1 or A2) to use for allocating a
new subject. To be precise, we define a parameter p (0ƒpƒ1). Then,
the new subject is allocated according to A1 rule with probability~p,
and to A2 rule with probability~1{p. This allocation scheme is
equivalent to a scheme that minimizes a weighted sum of d and D,
that is, to minimize S~Wdz(1{W)D, where W(W~1o r0 )i s
Bernoulli distributed with parameter p. Note that S above adopts a
‘stochastic’ weight (the weighting changes each time we allocate a
new subject) rather than the usual ‘deterministic’ weight (the
weighting is a fixed value). This makes the method robust to any
monotone transformation of d and D. In other words, all allocation
schemes that minimize S~Wf(d)z(1{W)g(D) are equivalent
for any monotonically increasing f(:) and g(:), and therefore one
need not worry about the functional forms.
Furthermore, the parameter p itself need not be fixed
throughout the course of allocation, either. It can be made to be
responsive to d, such that when d is larger (greater imbalance in
the total numbers of subjects), p is also larger (higher probability to
take action to counter that imbalance). We propose to base p on a
simple geometric accrual function: p~fc(d)~1{(1{c)
d, where
c(0vcv1) is a tuning parameter. This function has the following
properties: (1)p~0 when d~0; (2)p increases as d increases; and
(3)p?1 as d??. The role of the tuning parameter c is to govern
the accrual rate (an increase in c implies an increase in the accrual
rate). In the simulation studies that follow, we found that a tuning
value of c~0:05 is a satisfactory choice.
Results
Simulation Setups
We assume that there are a total of n subjects (indexed by i)t o
be allocated and a total of m prognostic factors (indexed by j)t ob e
Table 1. Biases and variances for the two-way minimization with c~0:05.
Sample Size Number and Type of Prognostic Factors Treatment Effect
0.0 0.5 1.0
Bias
20 Three binary prognostic factors 0.0031 0.0013 0.0073
Six binary prognostic factors 20.0042 0.0007 20.0012
Three polytomous prognostic factors 20.0061 0.0007 0.0016
40 Three binary prognostic factors 20.0095 20.0021 0.0023
Six binary prognostic factors 0.0052 0.0032 20.0012
Three polytomous prognostic factors 20.0039 0.0032 20.0028
Variance of estimates/Average of estimated variances
20 Three binary prognostic factors 0.2117/0.2123 0.2136/0.2124 0.2112/0.2128
Six binary prognostic factors 0.2306/0.2287 0.2253/0.2298 0.2289/0.2270
Three polytomous prognostic factors 0.2699/0.2741 0.2758/0.2711 0.2773/0.2720
40 Three binary prognostic factors 0.1009/0.1016 0.1029/0.1017 0.1042/0.1018
Six binary prognostic factors 0.1024/0.1034 0.1011/0.1031 0.1036/0.1035
Three polytomous prognostic factors 0.1109/0.1080 0.1081/0.1073 0.1059/0.1074
doi:10.1371/journal.pone.0028604.t001
Table 2. Type I error rates and powers at a significance level of 0.05 for the two-way minimization with c~0:05.
Sample Size Number and Type of Prognostic Factors Type I Error Rate Power
Treatment Effect=0.5 Treatment Effect=1.0
20 Three binary prognostic factors 0.0491 0.1738 0.5338
Six binary prognostic factors 0.0511 0.1569 0.4946
Three polytomous prognostic factors 0.0511 0.1457 0.4154
40 Three binary prognostic factors 0.0495 0.3339 0.8639
Six binary prognostic factors 0.0483 0.3268 0.8537
Three polytomous prognostic factors 0.0507 0.3192 0.8421
doi:10.1371/journal.pone.0028604.t002
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indicating the reference level) for the j th prognostic factor. Let xij
denote the factor level of the j th prognostic factor for the i th
subject (xij[ 1,:::,Lj
  
). Let ti denote the group to which the i th
subject is allocated, ti~1 if to the treatment group, and ti~0 if to
the control group. Let bt denote the treatment effect, bjk (bj1~0,
by definition), the effect of the kth level of the j th prognostic
factor. We generate the trial response for the i th subject from
a normal distribution with unit variance and a mean of
mi~bttiz
P m
j~1
P Lj
k~2
bjk|I(xij~k), where I(statement), an indica-
tor function, is 1 if the statement is true and 0 if otherwise.
In the simulation, the treatment effects are set at bt~0 (for
examining the type I error rates), bt~0:5 (for powers) and bt~1:0
(for powers), respectively. As for the prognostic factors, we
examine three scenarios: 1) three binary prognostic factors; 2) six
binary prognostic factors; and 3) three polytomous prognostic
factors, with number of levels of 5, 4 and 3, respectively. For a
binary prognostic factor, the probability of observing a non-
reference level is generated from a uniform[0.2, 0.8] distribution.
For a polytomous prognostic factor, we assume equal chances of
observing any of its levels. The factor levels, xij’s (for i~1,:::,n and
j~1,:::,m), are then generated from the corresponding binomial
distributions (for binary prognostic factors) or multinomial
distribution (for polytomous prognostic factors), respectively. The
effects, bjk’s (for j~1,:::,m and k~2,:::,Lj), are generated from a
uniform[0:8| b b,1 :2| b b] distribution, where  b b is the average
effect of the prognostic factors. In the simulation,  b b is examined for
various values.
We consider two different sample sizes: n~20 and 40. A total of
10,000 simulations are performed for each scenario. (To estimate a
p-value with the absolute relative error median level no larger than
5%, the number of simulations should be no less than 180=p [8].
With p~0.05, the number is 3600, justifying our use of 10,000
simulations.)
In each round of the simulation, we perform a multiple linear
regression with the dependent variable being the trial response,
and the independent variables, the ti and the xij’s. (If a prognostic
factor has more than two levels, say a total of 5, we enter all its 4
dummy variables into the regression model.) The estimate of the
treatment effect and its p-value are recorded. The bias is
calculated as the difference between the mean of the estimates
and its true value. The variance is calculated as the empirical
variance of the estimates across the 10,000 simulations. For
comparison, we also calculate the average of the estimated
variances from the multiple linear regression. The type I error rate
(under the null hypothesis: bt~0) and power (under the alternative
hypothesis: bt=0) are calculated as the proportion of the
simulations with the treatment-effect p-value,0.05.
In addition to the power and the variance described above,
predictability of treatment allocation is also an important criterion
for evaluating a trial (especially when perfection in masking/
concealment is difficult to achieve). If the allocation in a trial can
somehow be predicted, the study will be prone to selection bias. In
our simulation study, we derive two indices of predictability:
Predictability-I: defined as the probability that the next subject is
allocated to the group different from the one the previous subject
allocated to; and Predictability-II: defined as the probability that
the next subject is allocated to the group with fewer subjects
already allocated to.
Simulation Results
Figure 1 shows the performances (when bt~1:0) of the two-way
minimization using different c values (0 to 0.1, by 0.01), under a
smaller sample size of n~20. Figure 2 shows the corresponding
performances under a larger sample size of n~40. From both
figures, we see that to have better statistical performances (higher
power and smaller variance), one should choose a c value that is
larger. On the other hand to make the allocation less predictable,
one should choose a c value that is smaller. Taken together, we
settle on c~0:05 as a satisfactory compromise.
Table 1 shows the biases and variances for the two-way
minimization with c~0:05. We see that the two-way minimization
produces approximately unbiased estimates of the treatment
effects. We also see that the averages of the estimated variances
closely match with the corresponding empirical variances of the
estimates, indicating that the standard estimates of variances in a
multiple linear regression (with ti and dummy codes of xij’s as
regressors) are accurate, even for a complex allocation scheme
such as the two-way minimization. For hypothesis testing of the
treatment effect (at a significance level of 0.05), Table 2 shows that
the two-way minimization can maintain quite accurate type I error
rates, and that its power increases as the treatment effect increases.
Figure 3 compares the performances (when bt~1:0) of the two-
way minimization (c~0:05) with five other allocation methods: the
simple randomization, the block randomization (block size~4),
the stratified randomization (block size~4), the deterministic
minimization, and the biased coin minimization (coin
probability~0.7), under a smaller sample size of n~20. Figure 4
presents the corresponding results under a larger sample size of
n~40. We see that as the average effect of the prognostic factors
increases, the performances (in terms of power and variance) of the
simple randomization and the block randomization run down
quickly, whereas the performances of the four methods that
balance prognostic factors (the stratified randomization, the
deterministic minimization, the biased coin minimization, and
the two-way minimization) remain fairly stable. However, when
there are more prognostic factors (panels E and F) or more factor
levels (panels I and J) to be balanced (as compared to the situation
of three binary prognostic factors, panels A and B), the
performances of the stratified randomization and the biased coin
minimization deteriorate. By contrast, the deterministic minimi-
zation and the two-way minimization suffer very little performance
loss, if they are charged with balancing more prognostic factors or
more factor levels.
As for the allocation predictability (panels, C, D, G, H, K and L,
in Figures 3 and 4), we see that the deterministic minimization and
the block randomization are rather predictable. With these two
methods, an artful patient can have a 70:30 chance of getting what
he/she desires. The biased coin minimization shows some
improvement, though it is still not good enough (pre-
dictability&0:6). To have a satisfactory control of the selection
bias, one needs to turn to the stratified randomization or the
two-way minimization (predictabilityv,0.55), or to eliminate it
Figure 3. Performances of the two-way minimization with ª~0:05 (red star), as compared to those of the simple randomization
(black square), the block randomization with block size=4 (orange cross), the stratified randomization with block size=4 (green
triangle), the deterministic minimization (purple rhombus), and the biased coin minimization with coin probability=0.7 (blue
circle), under a smaller sample size of n~20 (left panels, A,D: with three binary prognostic factors; middle panels, E,H: with six
binary prognostic factors; right panels, I,L: with three polytomous prognostic factors). The treatment effect is set at 1.0.
doi:10.1371/journal.pone.0028604.g003
Two-Way Minimization
PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28604Figure 4. Performances of the two-way minimization with ª~0:05 (red star), as compared to those of the simple randomization
(black square), the block randomization with block size=4 (orange cross), the stratified randomization with block size=4 (green
triangle), the deterministic minimization (purple rhombus), and the biased coin minimization with coin probability=0.7 (blue
Two-Way Minimization
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dictability~0:5).
Discussion
In this study, we focused on trials with small sample sizes. We
showed that the proposed two-way minimization has the correct
type I error rates. It also produces point estimates that are
unbiased and variance estimates that are accurate. We compared
the performances of the new method with several existing
methods. Four methods can maintain stable performances as the
effects of prognostic factors increase, namely: 1) the stratified
randomization; 2) the biased coin minimization; 3) the determin-
istic minimization; and 4) the proposed two-way minimization.
However, the first three methods have drawbacks: the stratified
randomization and the biased coin minimization perform less than
ideally when they are charged with balancing more prognostic
factors/levels; the deterministic minimization is rather easy to
predict and is therefore prone to selection bias. By comparison, the
proposed two-way minimization is a better method for balancing
prognostic factors in small trials.
For a large trial, it is generally held that even a simple
randomization suffices. But there is no reason why one cannot
force balance a large trial using the two-way minimization. In fact
in doing so, he/she will be rewarded with even higher statistical
performances as compared to leaving everything to chance. For
example in a trial with n~1000 and six binary prognostic factors,
the powers are 0.6612 (two-way minimization) and 0.6113 (simple
randomization), the variances are 0.0039 (two-way minimization)
and 0.0045 (simple randomization), when the treatment effect is
0.15 and the effect of the prognostic factors is 0.3.
The two-way minimization may appear to be a fancy allocation
procedure that is unduly complex. Yet, the entire algorithm of it
can actually be incorporated into a simple spreadsheet program
(available from the authors). Then, all that a trial researcher has to
do is to simply feed in the prognostic-factor information for the
subjects consecutively recruited in the trial. The allocation for
them shall be produced one by one from the program fully
automatically. The two-way minimization also calls for simple
analysis despite its complex allocation scheme—a regression
adjustment for the force-balanced prognostic factors is all that is
needed. Further studies are warranted to extend the two-way
minimization to deal with unbalanced designs where the treatment
and the control groups are not to be of equal sample size due to
ethical or logistical considerations. More work is also needed to
study the performances of two-way minimization for other types of
trial response, such as non-normal, binary, Poisson, and time-to-
event data, etc, and whether the optimal value for the tuning
parameter of 0.05 that was identified remains optimal for these
other response types.
Recently, Perry et al. [9] also proposed an improved
minimization method, the ‘studywise minimization’. The method
exhaustedly searches among all possible allocations in a trial for
one that leads to minimum imbalance. It also has virtue of being
nearly unpredictable. However, the allocation of subjects (and also
the administering of the treatment) in that method has to be
deferred until all subjects intended for study has been recruited.
This essentially excludes its applicability in trials with extended
recruitment period and for treatments which must be immediately
given once subjects are recruited.
In conclusion, the proposed two-way minimization has desirable
statistical properties and is resistant to selection bias. The
allocation can be done in real time and the subsequent data
analysis is straightforward. The two-way minimization is recom-
mended to balance prognostic factors in small trials.
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